Mark R. Sannes

586 total citations
7 papers, 447 citations indexed

About

Mark R. Sannes is a scholar working on Epidemiology, Endocrinology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark R. Sannes has authored 7 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 3 papers in Endocrinology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark R. Sannes's work include Urinary Tract Infections Management (3 papers), Escherichia coli research studies (3 papers) and Antibiotic Resistance in Bacteria (2 papers). Mark R. Sannes is often cited by papers focused on Urinary Tract Infections Management (3 papers), Escherichia coli research studies (3 papers) and Antibiotic Resistance in Bacteria (2 papers). Mark R. Sannes collaborates with scholars based in United States and Japan. Mark R. Sannes's co-authors include Michael A. Kuskowski, James R. Johnson, James R. Johnson, Edward A. Belongia, Patricia Winokur, Jeff B. Bender, Connie Clabots, Kirk Smith, Krista Owens and Abby Gajewski and has published in prestigious journals such as The Journal of Infectious Diseases, Emerging infectious diseases and Nephrology Dialysis Transplantation.

In The Last Decade

Mark R. Sannes

7 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Sannes United States 6 215 212 120 109 74 7 447
María Eliecer Cano Spain 10 185 0.9× 257 1.2× 50 0.4× 111 1.0× 84 1.1× 14 463
Holly Ciesielczuk United Kingdom 10 234 1.1× 303 1.4× 85 0.7× 146 1.3× 42 0.6× 18 528
Céline Courroux France 13 204 0.9× 281 1.3× 51 0.4× 127 1.2× 88 1.2× 18 561
Gabriela Rodrigues Francisco Brazil 11 177 0.8× 363 1.7× 61 0.5× 75 0.7× 79 1.1× 18 463
Maria Fernanda Campagnari Bueno Brazil 11 174 0.8× 375 1.8× 57 0.5× 79 0.7× 80 1.1× 19 468
Frances Jamieson Canada 6 110 0.5× 208 1.0× 166 1.4× 67 0.6× 39 0.5× 7 460
L.-H. Su Taiwan 7 142 0.7× 254 1.2× 257 2.1× 82 0.8× 57 0.8× 8 508
Laure Coulange France 11 217 1.0× 439 2.1× 44 0.4× 151 1.4× 85 1.1× 12 495
G. Laurans France 14 189 0.9× 302 1.4× 71 0.6× 250 2.3× 50 0.7× 46 608
Maria Tärnberg Sweden 16 179 0.8× 388 1.8× 53 0.4× 144 1.3× 91 1.2× 21 558

Countries citing papers authored by Mark R. Sannes

Since Specialization
Citations

This map shows the geographic impact of Mark R. Sannes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Sannes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Sannes more than expected).

Fields of papers citing papers by Mark R. Sannes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Sannes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Sannes. The network helps show where Mark R. Sannes may publish in the future.

Co-authorship network of co-authors of Mark R. Sannes

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Sannes. A scholar is included among the top collaborators of Mark R. Sannes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Sannes. Mark R. Sannes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Williams, David N., Cristina Baker, A Kind, & Mark R. Sannes. (2015). The history and evolution of outpatient parenteral antibiotic therapy (OPAT). International Journal of Antimicrobial Agents. 46(3). 307–312. 74 indexed citations
2.
Sannes, Mark R., Edward A. Belongia, Burney A. Kieke, et al.. (2008). Predictors of Antimicrobial‐ResistantEscherichia coliin the Feces of Vegetarians and Newly Hospitalized Adults in Minnesota and Wisconsin. The Journal of Infectious Diseases. 197(3). 430–434. 26 indexed citations
3.
Johnson, James R., Mark R. Sannes, Brian Johnston, et al.. (2007). Antimicrobial Drug–Resistant Escherichia coli from Humans and Poultry Products, Minnesota and Wisconsin, 2002–2004. Emerging infectious diseases. 13(6). 838–846. 192 indexed citations
4.
Sannes, Mark R., Michael A. Kuskowski, & James R. Johnson. (2004). Antimicrobial resistance of Escherichia coli strains isolated from urine of women with cystitis or pyelonephritis and feces of dogs and healthy humans. Journal of the American Veterinary Medical Association. 225(3). 368–373. 22 indexed citations
5.
Sannes, Mark R., Michael A. Kuskowski, Krista Owens, Abby Gajewski, & James R. Johnson. (2004). Virulence Factor Profiles and Phylogenetic Background ofEscherichia coliIsolates from Veterans with Bacteremia and Uninfected Control Subjects. The Journal of Infectious Diseases. 190(12). 2121–2128. 102 indexed citations
6.
Sannes, Mark R., Michael A. Kuskowski, & James R. Johnson. (2004). Geographical distribution of antimicrobial resistance amongEscherichia colicausing acute uncomplicated pyelonephritis in the United States. FEMS Immunology & Medical Microbiology. 42(2). 213–218. 30 indexed citations
7.
Sannes, Mark R., et al.. (2000). Acute renal failure and thrombocytopenia after ticlopidine—not necessarily thrombotic thrombocytopenic purpura. Nephrology Dialysis Transplantation. 15(7). 1076–1079. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026